# GRAIL

GRAIL was founded in 2016 by Jeffrey Huber (former Google executive) as a spin-off from Illumina, and it began with an ambitious goal: to detect cancer early through blood-based genomic testing. It was backed by over $100 million in initial investment from Illumina, ARCH Venture Partners, and others, and GR
